TY - JOUR T1 - Correction: Tofacitinib for the treatment of moderately to severely active ulcerative colitis: a systematic review, network meta-analysis and economic evaluation JF - BMJ Open Gastroenterology JO - BMJ Open Gastro DO - 10.1136/bmjgast-2019-000302corr1 VL - 7 IS - 1 SP - e000302corr1 A2 - , Y1 - 2020/02/01 UR - http://bmjopengastro.bmj.com//content/7/1/e000302corr1.abstract N2 - Lohan C, Diamantopoulos A, LeReun C, et al. Tofacitinib for the treatment of moderately to severely active ulcerative colitis: a systematic review, network meta-analysis and economic evaluation. BMJ Open Gastro … ER -